ACUTAAS.NS Profit & Loss
Acutaas Chemicals Ltd.
Profit & Loss Balance Sheet Cash Flow
Profit & Loss · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 21:32
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Revenue from Operations | ₹616.73 Cr. | ₹717.47 Cr. | ₹1,006.88 Cr. | ₹1,339.37 Cr. | RevenueFromOperations |
| Gross Revenue (incl. inter-segment) | N/A | N/A | N/A | N/A | SegmentRevenueFromOperations |
| Other Income | ₹4.32 Cr. | ₹7.49 Cr. | ₹16.93 Cr. | ₹41.59 Cr. | OtherIncome |
| Total Income | ₹621.05 Cr. | ₹724.97 Cr. | ₹1,023.80 Cr. | ₹1,380.95 Cr. | Income |
| Cost of Materials Consumed | ₹345.85 Cr. | ₹440.17 Cr. | ₹569.81 Cr. | ₹594.96 Cr. | CostOfMaterialsConsumed |
| Purchases of Stock-in-Trade | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | PurchasesOfStockInTrade |
| Changes in Inventories | ₹-14.96 Cr. | ₹-28.48 Cr. | ₹-17.63 Cr. | ₹-29.00 Cr. | ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade |
| Employee Benefit Expense | ₹48.84 Cr. | ₹63.11 Cr. | ₹83.66 Cr. | ₹117.57 Cr. | EmployeeBenefitExpense |
| Finance Costs | ₹2.41 Cr. | ₹5.94 Cr. | ₹6.22 Cr. | ₹3.27 Cr. | FinanceCosts |
| Depreciation and Amortisation | ₹12.34 Cr. | ₹16.06 Cr. | ₹26.62 Cr. | ₹35.99 Cr. | DepreciationDepletionAndAmortisationExpense |
| Other Expenses | ₹114.40 Cr. | ₹114.18 Cr. | ₹138.96 Cr. | ₹175.44 Cr. | OtherExpenses |
| Total Expenses | ₹508.88 Cr. | ₹610.98 Cr. | ₹807.64 Cr. | ₹898.23 Cr. | Expenses |
| Profit Before Exceptional Items and Tax | ₹112.17 Cr. | ₹113.99 Cr. | ₹216.16 Cr. | ₹482.73 Cr. | ProfitBeforeExceptionalItemsAndTax |
| Exceptional Items | ₹0.00 Cr. | ₹-32.08 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ExceptionalItemsBeforeTax |
| Profit Before Tax | ₹112.17 Cr. | ₹81.90 Cr. | ₹216.16 Cr. | ₹482.73 Cr. | ProfitBeforeTax |
| Tax Expense | ₹28.88 Cr. | ₹33.19 Cr. | ₹55.75 Cr. | ₹126.36 Cr. | TaxExpense |
| Net Profit (incl. minority interest) | ₹83.29 Cr. | ₹48.71 Cr. | ₹160.42 Cr. | ₹356.37 Cr. | ProfitLossForPeriod |
| Net Profit (to shareholders) | ₹0.00 Cr. | ₹42.77 Cr. | ₹158.71 Cr. | ₹356.26 Cr. | ProfitOrLossAttributableToOwnersOfParent |
| Basic EPS | ₹22.86 | ₹11.67 | ₹19.81 | ₹43.51 | BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
| Diluted EPS | ₹22.86 | ₹11.66 | ₹19.81 | ₹43.37 | DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
Every figure above is the exact value of the named XBRL element from ACUTAAS.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).